Lanean...
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most eff...
Gorde:
| Argitaratua izan da: | Virol Sin |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Singapore
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779898/ https://ncbi.nlm.nih.gov/pubmed/33394351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12250-020-00327-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|